DOR BioPharma, Inc
Biotechnology - , ,
DOR BioPharma, Inc Employees
DOR BioPharma, Inc Details
DOR BioPharma, Inc. ( DOR ) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. DOR's lead product, orBec® (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD), a common and potentially life-threatening complication of allogeneic hematopoietic cell transplantation.
Website:
dorbiopharma.com
Employees:
1 - 10
HQ:
["3055343383","3055343553"]
Location:
, ,
Revenue:
DOR BioPharma, Inc Technologies
Load Balancers
Apache
Fonts
Google Font API
Other
Mobile Friendly